Home › Funds › SOUTHEASTERN ASSET MANAGEMENT INC/TN/ › ABT
SOUTHEASTERN ASSET MANAGEMENT INC/TN/ position in ABT
ABBOTT LABORATORIES · Health Care
SOUTHEASTERN ASSET MANAGEMENT INC/TN/ reported holding 836,792 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$82.7M, representing 4.54% of its reported portfolio and ranking #8 among its reported holdings. SOUTHEASTERN ASSET MANAGEMENT INC/TN/ has disclosed ABT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How SOUTHEASTERN ASSET MANAGEMENT INC/TN/'s ABT position evolved
SOUTHEASTERN ASSET MANAGEMENT INC/TN/ first disclosed a stake in ABT in Q2 2026 at 840,747 shares (US$76.3M). The position peaked in Q3 2026 at 836,792 shares, worth US$82.7M. Across 2 filings, SOUTHEASTERN ASSET MANAGEMENT INC/TN/ held the position steady without any share-count change. The most recent filing (Q3 2026) shows 836,792 shares valued at US$82.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 840.75K | $76.29M | New |
| Q3 2026 | 836.79K | $82.70M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABT and 13F data
ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.65B), Charles Schwab Investment Management (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABT
- Vanguard Group 175.56M sh · $22.00B · Q4 2025
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 57.16M sh · $5.65B · Q3 2026
- Charles Schwab Investment Management 59.67M sh · $5.41B · Q2 2026
- Capital Research Global Investors 44.98M sh · $4.45B · Q3 2026
- Capital International Investors 35.46M sh · $3.51B · Q3 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Franklin Resources 20.44M sh · $2.36B · Q3 2026
- Deutsche Bank AG 17.69M sh · $1.75B · Q3 2026
- MFS Investment Management 14.93M sh · $1.48B · Q3 2026
More on SOUTHEASTERN ASSET MANAGEMENT INC/TN/
FAQ
How long has SOUTHEASTERN ASSET MANAGEMENT INC/TN/ held ABT?
SOUTHEASTERN ASSET MANAGEMENT INC/TN/ has disclosed ABT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is SOUTHEASTERN ASSET MANAGEMENT INC/TN/'s current position in ABT?
As of Q3 2026, SOUTHEASTERN ASSET MANAGEMENT INC/TN/ holds 836.79K shares of ABT (ABBOTT LABORATORIES), valued at $82.70M, representing 4.54% of its reported portfolio and ranking #8.
Has SOUTHEASTERN ASSET MANAGEMENT INC/TN/ been buying or selling ABT?
In the latest 13F filing (Q3 2026), SOUTHEASTERN ASSET MANAGEMENT INC/TN/ held unchanged its position in ABT. The position peaked in Q3 2026 at 836.79K shares.
Which other funds hold ABT?
Other major institutional holders of ABT include Vanguard Group, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Charles Schwab Investment Management, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.